Equities research analysts at StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a report issued on Monday. The brokerage set a “buy” rating on the stock.
Mannatech Stock Down 7.3 %
NASDAQ MTEX opened at $9.69 on Monday. Mannatech has a 1-year low of $6.75 and a 1-year high of $16.49. The company has a market capitalization of $18.41 million, a price-to-earnings ratio of -11.96 and a beta of 1.06. The stock’s 50 day moving average is $9.94 and its two-hundred day moving average is $10.43. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its earnings results on Wednesday, March 26th. The company reported $1.20 EPS for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The business had revenue of $29.01 million during the quarter.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- What is a buyback in stocks? A comprehensive guide for investors
- Western Digital: Is the Storage Sector Set for a Rebound?
- What is a Dividend King?
- Wingstop Stock Jumps on Q1 Beat, Expansion Outlook
- Using the MarketBeat Dividend Tax Calculator
- Why Energy Stocks Like Exxon and Hess Are Back in Focus
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
